A-New Bio Inc. was selected for work supporting innovation in poultry biotechnology and avian influenza resistance.
A-New Bio Inc. / ANB
Advancing the Future of Cell Manufacturing
ANB develops proprietary culture technologies designed to support the long-term maintenance and scalable expansion of stem cells and progenitor cells.
01 / Platforms
Technology Platforms
ANB is developing proprietary culture technologies for blood stem cell and avian stem cell platforms. The company’s work focuses on maintaining cellular quality, functional potential, and manufacturing consistency.
Blood Stem Cell Technologies
Culture systems designed to support the maintenance and expansion of blood-forming stem and progenitor cells for future research and therapeutic applications.
Avian Stem Cell Technologies
Stem cell platforms supporting avian genetic engineering, agricultural biotechnology, and next-generation research models.
02 / Applications
Applications & Partnerships
ANB is developing proprietary culture technologies that support the development and manufacturing of advanced cellular products.
03 / News
News & Updates
ANB continues to advance avian embryonic stem cell technologies for genetic engineering and agricultural biotechnology applications.
04 / Leadership
Founding Leadership
Leads corporate strategy, business development, financing strategy, partnerships, and company operations.
Leads scientific vision and platform innovation across stem cell culture technologies and translational research programs.
Leads operational execution, translational development, program planning, and research-to-product advancement.
Contributes to platform development, experimental execution, and stem cell technology innovation.
05 / Contact
Contact ANB
For partnership, research collaboration, business development, or investor inquiries, please contact:
xdp@a-newbio.com